drugset / Trial / NCT02255032
Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The study is designed to evaluate the safety and efficacy of triamcinolone acetonide, CLS-TA, in subjects with macular edema following non-infectious uveitis. A single suprachoroidal injection of one of two doses of CLS-TA will each be evaluated in subjects with macular edema following non-infectious uveitis.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-12
- Completion
- 2016-01
Outcome
Met primary endpoint
registry analysis (superiority test); 4 mg CLS-TA; p = 0.0017; Mean Difference (Final Values) -164.44 (95% CI -256.7 to -72.2) NCT02255032 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triamcinolone Acetonide | Other / unclassified | 0.8 mg | Other |
| Subject | Triamcinolone Acetonide | Other / unclassified | 4 mg | Other |